An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia
Phase 1
Active, not recruiting
- Conditions
- Relapsed AMLAdvanced Solid TumorRefractory AML
- Interventions
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- New Epsilon Innovation Limited
- Target Recruit Count
- 24
- Registration Number
- NCT05226468
- Locations
- ðŸ‡ðŸ‡°
The University of Hong Kong Phase I Clinical Trials Centre, Hong Kong, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath